evofloxacin effect on eradication of Helicobacter Pylori infectio
- Conditions
- Helicobacter Pylori infection.Helicobacter pylori
- Registration Number
- IRCT2015081818124N2
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion criteria to this study: all patients undergoing upper endoscopic procedure with positive rapid urease test (RUT). Exclusion criteria from this study: pregnancy; Previous consumption proton pump inhibitors (PPI) or Bismuth in the preceding one month; Gastrointestinal (GI) bleeding or any complication of peptic ulcer disease (PUD); consumption of alcohol or substance; advanced chronic disease: Diabetes mellitus, Hypertension, Cirrhosis, Cerebrovascular attack, Renal insufficiency, Coronary artery disease and gastric cancer; lack of willingness to continue the treatment; lack of willingness to complete the period of treatment; suffering from any disease needing to consume another antibiotic or non-steroidal anti-inflammatory drugs (NSAIDs).
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication of Helicobacter Pylori infection. Timepoint: Two months after beginning of treatment. Method of measurement: Primary evaluation of Helicobacter Pylori infection is based on rapid urease test and then eradication will be assessed by Helicobacter Pylori stool antigen.
- Secondary Outcome Measures
Name Time Method